Literature DB >> 11115598

Mycosis fungoides and pregnancy.

C Castelo-Branco1, A Torné, V Cararach, X Iglesias.   

Abstract

Mycosis fungoides is a cutaneous T-cell lymphoma, a subgroup of non-Hodgkin's lymphomas, characterized by skin infiltration and occasionally systemic involvement. The association of pregnancy and mycosis fungoides has not been described previously. A case of mycosis fungoides, stage IVb, in a pregnant woman is reported. Prior to pregnancy, the patient received adriamycin, cyclophosphamide, vincristine prednisolone (CHOP) and bleomycin and total body irradiation. Around the concepcional period she presented a cutaneous relapse palliated with photon radiotherapy. No obstetrics complications were observed during gestation. At 39 week's gestation a cesarean section was performed and a healthy 2900 g boy was delivered. Mycosis fungoides did not worsen during pregnancy and postpartum period. In conclusion mycosis fungoides did not adversely affect pregnancy outcome and gestation did not worsen the malignancy course. This case report may be valuable in managing patients with mycosis fungoides who are currently pregnant or are contemplating pregnancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11115598     DOI: 10.3892/or.8.1.197

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Cutaneous T-cell lymphoma and pregnancy: Great uncertainty and an appeal for prospective clinical research.

Authors:  Tessa M LeWitt; Christina J Walker; Maria L Espinosa; Christopher Chung; Xiaolong Alan Zhou; Joan Guitart
Journal:  J Am Acad Dermatol       Date:  2021-10-29       Impact factor: 15.487

2.  CD30+ Large Cell Transformation of Mycosis Fungoides During Pregnancy.

Authors:  Farahnaz Fatemi Naeini; Jamshid Najafian; Mohammadali Nilforoushzadeh
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

3.  Correlation between mycosis fungoides and pregnancy.

Authors:  Farahnaz Fatemi Naeini; Bahareh Abtahi-Naeini; Jamshid Najafian; Ali Saffaei; Mohsen Pourazizi
Journal:  Saudi Med J       Date:  2016-09       Impact factor: 1.484

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.